COMMUNIQUÉS West-GlobeNewswire

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

01/05/2025 - 22:20

CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications [...]

MacroGenics to Participate in Upcoming Investor Conference

01/05/2025 - 22:30

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics [...]

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

01/05/2025 - 22:30

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

01/05/2025 - 22:30

New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions ( [...]

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01/05/2025 - 23:00

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for [...]

Precipio Announces Q1-2025 Shareholder Update Call

01/05/2025 - 23:00

Conference Call to be held on May 15th, 2025 at 5:00 PM EST NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2025 corporate [...]

Premier Health Announces Results of Shareholders’ Meeting

01/05/2025 - 23:00

MONTRÉAL, May 01, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “ Corporation ” or “ Premier Health ”), a leading Canadian Healthtech company, announces that all matters submitted to [...]

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

01/05/2025 - 23:00

FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today [...]

Coherus to Participate in Upcoming Investor Conferences

01/05/2025 - 23:04

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life [...]

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

01/05/2025 - 23:07

Agreement will facilitate widespread distribution of NARCAN® Nasal Spray throughout Ontario WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three- [...]

Sumatra Slim Belly Tonic Reviews (URGENT REPORT) What Consumers Say About This Blue Tonic for Weight Loss?

01/05/2025 - 19:05

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Losing weight in today’s world is more challenging than ever. Despite countless diets, exercise routines, and trendy supplements, millions still struggle with stubborn fat, [...]

ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis

01/05/2025 - 19:30

Special Meeting of stockholders to vote on the transaction scheduled for May 13, 2025 Reminds stockholders to vote today FOR the proposed merger LOS ANGELES, May 01, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, Inc. (Nasdaq: SLRN [...]

Ultrack Systems Inc. (OTC: MJLB) Signs MOU to Acquire Better Pets, a Leading Health-Focused Pet Product Brand

01/05/2025 - 20:00

CONCORD, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) ("Ultrack" or the "Company") is pleased to announce it has entered into a Memorandum of Understanding (MOU) to acquire Better Pets, a [...]

Comprehensive Healthcare Announces Grand Opening of Second Permanent Supportive Housing Facility to Serve the Lower Yakima Valley

01/05/2025 - 20:05

YAKIMA, Wash., May 01, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced the expansion of its permanent supportive housing program in Sunnyside with the opening of Vista Del Sol-2 (VDS-2), a 20-unit long [...]

Best SARMs 2025: Strongest SARMs for Bulking, Cutting, Muscle Growth and Strength: Are SARMs Legal Or Safe? Best Sarm for Fat Loss - CrazyBulk

01/05/2025 - 20:09

Best SARMs For Bulking, Cutting, Strength & Muscle Growth Using SARMs to build strength and muscles is a common strategy, but are SARMs for strength and muscle development actually the best option for you? In this [...]

Eascra Biotech Expands Operations with a New Worcester Lab

01/05/2025 - 20:21

Nanomedicine startup to conduct research and testing in the MBI facility BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts [...]

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

01/05/2025 - 20:38

The initiative is a social media challenge ahead of Global AK Awareness Day, on May 24, which supports the work of The Skin Cancer Foundation and Euromelanoma The Hats On Challenge provides an opportunity to take part [...]

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

01/05/2025 - 21:00

JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2025 - 22:00

CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]